CoQ10 is also know as ubiquinone.

Doctor’s Report

(Stephen Sinatra, M.D., F.A.C.C., Board-Certified Cardiologist and Certified Bioenergetic Psychotherapist. He is the Director of Medical Education at the Manchester Memorial Hospital and a professor of medicine at the University of Connecticut School of medicine.)

CoQ10 first came to my attention in 1982 when I read a journal article reporting on its effectiveness in helping a patient recover from major surgery. I was intrigued, so I clipped the article. However, like most of my colleagues, I still had some bias against simple ‘nonpharmaceutical compounds, vitamins and cofactors’. I failed to appreciate that their effects could be so dramatic.

It took me four years to become convinced enough to let go of my rigid conventional medical thinking. In 1986 I began to integrate CoQ10 into my cardiology practice. I was highly impressed with the results and soon became committed to spreading the word about this remarkable compound. In the last dozen years, I have recommended CoQ10 for thousands of patients in my medical practice.

As a specialist, it is unthinkable for me to practice good cardiology without the help of CoQ10. I believe that it is one of the greatest medicinal advances in the 20th century for the treatment of heart disease. For the thousands of people with cardiac conditions so severe that they need a heart transplant, CoQ10 may be a suitable alternative that not only enhances quality of life, but extends survival as well.

Research has shown that CoQ10 is an indisputable heart remedy, but most doctors have never even heard of it. And even those physicians who are aware of CoQ10, most likely dismiss it. Why is this so?

Although CoenzymeQ10 represents the greatest potential breakthrough for cardiovascular disease and many other illnesses, the resistance of the medical profession to using this essential nutrient represents one of the greatest potential tragedies in medicine. Hundreds of scientific studies and thousands of clinical applications have documented that this substance has proven benefits for treating a wide variety of clinical cardiac conditions including:

• Congestive heart failure
• High blood pressure
• Angina
• Arrhythmia
• Aortic valve disease
• Coronary artery disease
• As well as other cardiological situations

Yet, despite: a large body of available information, a therapeutic description in a 1997 textbook* of mainstream cardiology, and the fact that CoQ10 is used by many board-certified cardiologists in the U.S. as well as Europe and Japan, it is still virtually ignored by the majority of clinical cardiologists and most of the conventional medical establishment as well.

(*Innovative Pharmacologic Approaches for the Treatment of Myocardial Ischemia – W.H.
Frishman – McGraw-Hill)

1. It is difficult for highly trained medical personnel, well-versed in pharmacology and technology to believe that anything so simple and so natural can be as effective as the highly engineered drugs modern medicine has to offer.
2. Most cardiologists cannot acknowledge that a natural substance not manufactured by pharmaceutical industry giants could be so valuable. These factors have rendered CoenzymeQ10 a victim of politics, bias, insufficient marketing, economics and ignorance of the results of real science.
3. Another blockade has been the patent issue. Since CoenzymeQ10 is not patentable, there is no economic incentive for major pharmacological companies to develop it as a product.

Quality

It is important to look at issues of therapeutic bioavailability and absorption whenever we supplement with this nutrient. Absorption of CoQ10 is a challenge. Until now, there have been three basic types:

1. Solid form
2. Soft gel caps with oils
3. Soft gel caps with oils (with added chemicals to attempt to boost absorption)

Patients may not respond if they cannot absorb a supplement. The product formulation may be at fault:

• it may not contain enough pure CoQ10
• or it may lack bioavailability because of compounds or fillers in the preparation it may not be very soluable

Blood levels will indicated whether the CoQ10 is being absorbed and delivered to tissues and organs. When it is delivered in sufficient dosage, it will support the tissues in need.

The Shaklee Difference

Shaklee has a patented delivery system clinically proven to absorb:

• 500% better than the solid form
• 333% better than the soft gels
• 33% better than the leading soft gels (enhanced with chemicals)

Shaklee’s CoenzymeQ10 also contains Resveratrol which:

• is a powerful antioxidant found in red grapes or the roots of a Chinese herb (polygonum Cuspidatum)
• according to the British Medical Journal, “The Lancet”, it inhibits LDL cholesterol oxidation by an amazing 70 to 80%
• helps blood vessels to relax and dilate which facilitates blood flowing freely through the arteries
• stabilizes heart rhythm

One capsule meets your daily needs.

High bioavailability means you take less, but you get more.

This clinically proven super-enhanced absorption is the result of a patented technology exclusive to Shaklee, using all-natural ingredients.

Shaklee CoenzymeQ10 is the ONLY product on the marketplace that offers CoQ10 and Resveratrol.

History of CoenzymeQ10

It was first discovered in 1957. The first organized clinical trial on humans was done in the mid 1960’s.

By 1982, CoQ10 had reached a level of consumption in Japan that rivaled that country’s top five medications. It has been Japanese, and later European scientists and physicians who have conducted the majority of clinical trials employing CoQ10.

In 1990s, it became a top-selling supplement in health food stores.

As of 1997, there have been over 100 observational, epidemiological and population studies done on it, and at least 19 placebo-controlled trials.

As of 1996 there are over 350 papers presented by over 200 different physicians and scientists from 18 different countries who recommend use of CoQ10 in a wide range of medical disorders.

But in spite of all of this published research, very few physicians have heard of CoQ10, know how it works or recommend it to those patients whom it would benefit. Therefore, those who could guide the public best about when and how to use CoQ10, are ignorant and disinterested in it.

Is CoenzymeQ10 Safe?

A massive review of the literature pertaining to safety and efficacy of CoQ10 in congestive heart failure, angina, and high blood pressure was published in the Journal of Pharmacotherapy in July 2001 they used relevant clinical trials, articles and reviews form three huge data bases covering the period from 1974 through 2000. According to Dr. M.T. Tran, lead author of the study, “CoenzymeQ10 administered orally has favorable actions in the described cardiovascular conditions and appears to be safe and well tolerated in the adult population.” The studies showed:

• an increase in the capacity for work and play,
• fewer episodes of angina pain,
• fewer drugs needed,
• less hospitalization
• and greatly improved quality of life

In Japan where CoQ10 has been used since the 1960s, results showed improvement in 70 to 75 percent of the patients. It has been prescribed for more than 40 million heart patients worldwide.

It has been approved in Japan and Europe for the treatment of congestive heart disease.

For more information consider getting 'The Coenzyme Q10 Phenomenon' by Stephen T., M.D. Sinatra.

More CoQ10 information

Buy Unique, highly bioavailable CoQ10!

*

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.